Macdonald D R, Gaspar L E, Cairncross J G
Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Ann Neurol. 1990 May;27(5):573-4. doi: 10.1002/ana.410270519.
We treated 3 patients with newly diagnosed aggressive oligodendroglioma with chemotherapy prior to radiotherapy and observed responses. All had residual or progressive tumor following initial surgery. We used a combination called PCV-3 because recurrent anaplastic oligodendroglioma responds predictably to this regimen. Chemotherapy for response induction followed by radiotherapy for consolidation is feasible and effective initial treatment for this tumor.
我们对3例新诊断的侵袭性少突胶质细胞瘤患者在放疗前进行了化疗并观察反应。所有患者在初次手术后均有残留或进展性肿瘤。我们使用了一种名为PCV-3的联合方案,因为复发性间变性少突胶质细胞瘤对该方案有可预测的反应。化疗诱导反应后进行放疗巩固是这种肿瘤可行且有效的初始治疗方法。